{"id":"W2990938107","doi":"10.1080/10428194.2019.1688320","title":"Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Cytarabine; Daunorubicin; Internal medicine; Myeloid leukemia; Population; Leukemia; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007504465,0.001823287,0.002738753,0.001481962,0.0005047147,0.0003049354,0.0008794932,0.001295503,0.0007782045],"category_scores_gemma":[0.0003081006,0.001511645,0.0004377246,0.001896723,0.0007653848,0.001257246,0.0005876448,0.001040021,0.0009980996],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02898004,"about_ca_system_score_gemma":0.009832718,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01114337,"about_ca_topic_score_gemma":0.0005981451,"domain_scores_codex":[0.9905753,0.0004670769,0.001841755,0.002621412,0.001976839,0.002517639],"domain_scores_gemma":[0.9939256,0.001072466,0.0008585933,0.002272102,0.0006994522,0.001171811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01643338,0.0006285358,0.8918961,0.0004695086,0.002072982,0.001055012,0.001059404,0.000198891,0.002509045,0.0003936952,0.003152217,0.08013127],"study_design_scores_gemma":[0.1310157,0.002335869,0.8504254,0.0005032409,0.0008826369,0.0002844069,0.0004998541,0.002301486,0.006285353,0.00007311339,0.003760721,0.001632256],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881079,0.0004454186,0.00003669634,0.0002735313,0.000802284,0.003535712,0.0003799605,0.0005241889,0.005894375],"genre_scores_gemma":[0.9886045,0.0009454369,0.001087565,0.001307111,0.0002596578,0.0003163048,0.001892623,0.0004045778,0.005182233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1145823,"threshold_uncertainty_score":0.9997798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006292642361575587,"score_gpt":0.2358089261766824,"score_spread":0.2295162838151068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}